Shashank Dave, DO
Physical Medicine & Rehabilitation · Indianapolis, INNPI 1447214440
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $156,800 of the $198,022 with a category attached, or 79.2%. AbbVie accounts for 99.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $78,555 and has fallen 82.7% since, to $13,576 in 2025. Among physical medicine & rehabilitation clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 225 payments — averaging $880.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$198K
- SPR Therapeutics, Inc$139
- Vertos Medical, Inc.$111
- Medtronic$87
- Merz Pharmaceuticals, LLC$74
- Abbott$34
- plus $59 from 3 others
What the payments were for
- Consulting fees$30,60015%
- Speaking & faculty fees$156,80079%
- Travel & lodging$7,1294%
- Food & beverage$3,4932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 212 | $197,520 |
| SPR Therapeutics, Inc | 5 | $139 |
| Vertos Medical, Inc. | 1 | $111 |
| Medtronic | 1 | $87 |
| Merz Pharmaceuticals, LLC | 1 | $74 |
| Abbott | 2 | $34 |
| Averitas Pharma Inc. | 1 | $24 |
| Amgen | 1 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$190,730
- DURYSTA$250
- mild Device Kit$111
How this compares
$198,022 in reported general payments places this provider in the 95th percentile of 140 physical medicine & rehabilitation providers in Indiana.
See all physical medicine & rehabilitation providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 81 | $3,989 |
| Dantrolene Sodium | 31 | $3,029 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $1,104 |
| Gabapentin | 48 | $1,044 |
| Pregabalin | 22 | $1,022 |
| Tizanidine Hcl | 39 | $818 |
| Diazepam | 21 | $662 |
| Cyclobenzaprine Hcl | 18 | $200 |
| Tramadol Hcl | 18 | $71 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Indianapolis
- Sachin MehtaIndianapolis$60K
- Anthony MimmsIndianapolis$10K
- Flora HammondIndianapolis$9K
- Eric AitkenIndianapolis$5K
- Kyle MazellanIndianapolis$2K
- Abhishek ReddyIndianapolis$2K
- Dianne LeachIndianapolis$2K
- Raghu MaddelaIndianapolis$2K
- Anand NavarasalaIndianapolis$2K
- Shiva GangadharIndianapolis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.